ABBVIE INC. vs. Adial Pharmaceuticals, Inc
ABBVIE INC. and Adial Pharmaceuticals, Inc are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | ADIL | |
|---|---|---|
| Market Cap | $434.78 billion | $8.71 million |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-7,770,762 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | ADIL | |
|---|---|---|
| Price / Book | — | 2.34 |
ABBV and ADIL split the valuation factors evenly.
Profitability
| ABBV | ADIL | |
|---|---|---|
| Return on Equity | — | -209.05% |
ABBV and ADIL split the profitability factors evenly.
Risk & Sentiment
| ABBV | ADIL | |
|---|---|---|
| Short Interest | 0.85% | 0.00% |
ADIL leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, ADIL overview, ADIL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.